deltatrials
Completed PHASE4 NCT00330577

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

Sponsor: Aristotle University Of Thessaloniki

Conditions Ocular Hypertension Primary Open Angle Glaucoma
Interventions latanoprost/timolol fixed combination placebo (artificial tears) timolol maleate 0.5%
Updated 5 times since 2017 Last updated: May 9, 2014 Started: Apr 30, 2006 Primary completion: Apr 30, 2007 Completion: Jul 31, 2007

A PHASE4 clinical study on Ocular Hypertension and Primary Open Angle Glaucoma, this trial is completed. The trial is conducted by Aristotle University Of Thessaloniki and has accumulated 5 data snapshots since 2006. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Aristotle University Of Thessaloniki
Data source: Aristotle University Of Thessaloniki

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Thessaloniki, Greece